Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER-Medicare investigation.

Beebe-Dimmer JL, Ruterbusch JJ, Cooney KA, Bolton A, Schwartz K, Schwartz AG, Heath E.

Cancer Med. 2019 Jun;8(6):3325-3335. doi: 10.1002/cam4.2092. Epub 2019 May 15.

2.

Fossil Atmospheres: a case study of citizen science in question-driven palaeontological research.

Soul LC, Barclay RS, Bolton A, Wing SL.

Philos Trans R Soc Lond B Biol Sci. 2018 Nov 19;374(1763). pii: 20170388. doi: 10.1098/rstb.2017.0388.

PMID:
30455206
3.

High-throughput screening for selective appetite modulators: A multibehavioral and translational drug discovery strategy.

Jordi J, Guggiana-Nilo D, Bolton AD, Prabha S, Ballotti K, Herrera K, Rennekamp AJ, Peterson RT, Lutz TA, Engert F.

Sci Adv. 2018 Oct 31;4(10):eaav1966. doi: 10.1126/sciadv.aav1966. eCollection 2018 Oct.

4.

Frames of Reference in Self-Reports of Health, Well-being, Fatigue, and Pain: A Qualitative Examination.

Junghaenel DU, Broderick JE, Schneider S, May M, Bolton A, McCarrier KP, Stassek LM, Keithly SC, Stone AA.

Appl Res Qual Life. 2018 Sep;13(3):585-601. doi: 10.1007/s11482-017-9546-3. Epub 2017 Jul 6.

PMID:
30344794
5.

Synaptic Effects of Dopamine Breakdown and Their Relation to Schizophrenia-Linked Working Memory Deficits.

Bolton AD, Constantine-Paton M.

Front Synaptic Neurosci. 2018 Jun 12;10:16. doi: 10.3389/fnsyn.2018.00016. eCollection 2018.

6.

Assessing the Efficiency of Phenotyping Early Traits in a Greenhouse Automated Platform for Predicting Drought Tolerance of Soybean in the Field.

Peirone LS, Pereyra Irujo GA, Bolton A, Erreguerena I, Aguirrezábal LAN.

Front Plant Sci. 2018 May 3;9:587. doi: 10.3389/fpls.2018.00587. eCollection 2018.

7.

Defining Medical Student Patient Care Responsibilities Before Intern Year: Results of a National Survey.

King CJ, Bolton A, Guerrasio J, Trosterman A.

South Med J. 2017 Dec;110(12):765-769. doi: 10.14423/SMJ.0000000000000738.

PMID:
29197310
8.

Mastering the game of Go without human knowledge.

Silver D, Schrittwieser J, Simonyan K, Antonoglou I, Huang A, Guez A, Hubert T, Baker L, Lai M, Bolton A, Chen Y, Lillicrap T, Hui F, Sifre L, van den Driessche G, Graepel T, Hassabis D.

Nature. 2017 Oct 18;550(7676):354-359. doi: 10.1038/nature24270.

PMID:
29052630
9.

A Diencephalic Dopamine Source Provides Input to the Superior Colliculus, where D1 and D2 Receptors Segregate to Distinct Functional Zones.

Bolton AD, Murata Y, Kirchner R, Kim SY, Young A, Dang T, Yanagawa Y, Constantine-Paton M.

Cell Rep. 2015 Nov 3;13(5):1003-15. doi: 10.1016/j.celrep.2015.09.046. Epub 2015 Oct 22.

10.

Telepsychology for Posttraumatic Stress Disorder: A systematic review.

Bolton AJ, Dorstyn DS.

J Telemed Telecare. 2015 Jul;21(5):254-67. doi: 10.1177/1357633X15571996. Epub 2015 Feb 22. Review.

PMID:
25712113
11.

Regional neurodegeneration and gliosis are amplified by mild traumatic brain injury repeated at 24-hour intervals.

Bolton AN, Saatman KE.

J Neuropathol Exp Neurol. 2014 Oct;73(10):933-47. doi: 10.1097/NEN.0000000000000115.

12.

Homocysteine reduces NMDAR desensitization and differentially modulates peak amplitude of NMDAR currents, depending on GluN2 subunit composition.

Bolton AD, Phillips MA, Constantine-Paton M.

J Neurophysiol. 2013 Oct;110(7):1567-82. doi: 10.1152/jn.00809.2012. Epub 2013 Jul 17.

13.

Visual improvement following continuous positive airway pressure therapy in diabetic subjects with clinically significant macular oedema and obstructive sleep apnoea: proof of principle study.

Mason RH, Kiire CA, Groves DC, Lipinski HJ, Jaycock A, Winter BC, Smith L, Bolton A, Rahman NM, Swaminathan R, Chong VN, Stradling JR.

Respiration. 2012;84(4):275-82. Epub 2011 Dec 20.

14.

Genomic and epigenomic instability, fragile sites, schizophrenia and autism.

Smith CL, Bolton A, Nguyen G.

Curr Genomics. 2010 Sep;11(6):447-69. doi: 10.2174/138920210793176001.

15.

Distinct roles of NR2A and NR2B cytoplasmic tails in long-term potentiation.

Foster KA, McLaughlin N, Edbauer D, Phillips M, Bolton A, Constantine-Paton M, Sheng M.

J Neurosci. 2010 Feb 17;30(7):2676-85. doi: 10.1523/JNEUROSCI.4022-09.2010.

16.

Lethal skeletal dysplasia in mice and humans lacking the golgin GMAP-210.

Smits P, Bolton AD, Funari V, Hong M, Boyden ED, Lu L, Manning DK, Dwyer ND, Moran JL, Prysak M, Merriman B, Nelson SF, Bonafé L, Superti-Furga A, Ikegawa S, Krakow D, Cohn DH, Kirchhausen T, Warman ML, Beier DR.

N Engl J Med. 2010 Jan 21;362(3):206-16. doi: 10.1056/NEJMoa0900158.

17.

A novel phospholipid-based drug formulation, VP025, modulates age- and LPS-induced microglial activity in the rat.

Martin DS, Walsh M, Miller AM, Skerrett HE, Byrne P, Mandel A, Bolton AE, Lynch MA.

Neuroimmunomodulation. 2009;16(6):400-10. doi: 10.1159/000228915. Epub 2009 Jul 17.

PMID:
19609089
18.

Trends in wood dust inhalation exposure in the UK, 1985-2005.

Galea KS, Van Tongeren M, Sleeuwenhoek AJ, While D, Graham M, Bolton A, Kromhout H, Cherrie JW.

Ann Occup Hyg. 2009 Oct;53(7):657-67. doi: 10.1093/annhyg/mep044. Epub 2009 Jul 14.

PMID:
19602501
19.

Expression, bioactivity, and safety 1 year after adeno-associated viral vector type 2-mediated delivery of neurturin to the monkey nigrostriatal system support cere-120 for Parkinson's disease.

Herzog CD, Brown L, Gammon D, Kruegel B, Lin R, Wilson A, Bolton A, Printz M, Gasmi M, Bishop KM, Kordower JH, Bartus RT.

Neurosurgery. 2009 Apr;64(4):602-12; discussion 612-3. doi: 10.1227/01.NEU.0000340682.06068.01.

PMID:
19349823
20.

The deficit in long-term potentiation induced by chronic administration of amyloid-beta is attenuated by treatment of rats with a novel phospholipid-based drug formulation, VP025.

Miller AM, Piazza A, Martin DS, Walsh M, Mandel A, Bolton AE, Lynch MA.

Exp Gerontol. 2009 Apr;44(4):300-4. doi: 10.1016/j.exger.2008.12.001. Epub 2008 Dec 11.

PMID:
19121379
21.

Treatment with phosphotidylglycerol-based nanoparticles prevents motor deficits induced by proteasome inhibition: implications for Parkinson's disease.

Fitzgerald P, Mandel A, Bolton AE, Sullivan AM, Nolan Y.

Behav Brain Res. 2008 Dec 22;195(2):271-4. doi: 10.1016/j.bbr.2008.08.041. Epub 2008 Sep 4.

PMID:
18817814
22.

Neuroprotective effects of novel phosphatidylglycerol-based phospholipids in the 6-hydroxydopamine model of Parkinson's disease.

Crotty S, Fitzgerald P, Tuohy E, Harris DM, Fisher A, Mandel A, Bolton AE, Sullivan AM, Nolan Y.

Eur J Neurosci. 2008 Jan;27(2):294-300. doi: 10.1111/j.1460-9568.2007.06018.x. Epub 2008 Jan 11.

PMID:
18190522
23.

The incidence of occupational skin disease as reported to The Health and Occupation Reporting (THOR) network between 2002 and 2005.

Turner S, Carder M, van Tongeren M, McNamee R, Lines S, Hussey L, Bolton A, Beck MH, Wilkinson M, Agius R.

Br J Dermatol. 2007 Oct;157(4):713-22. Epub 2007 Jun 26.

PMID:
17596159
24.
25.

Utilization of a whole genome SNP panel for efficient genetic mapping in the mouse.

Moran JL, Bolton AD, Tran PV, Brown A, Dwyer ND, Manning DK, Bjork BC, Li C, Montgomery K, Siepka SM, Vitaterna MH, Takahashi JS, Wiltshire T, Kwiatkowski DJ, Kucherlapati R, Beier DR.

Genome Res. 2006 Mar;16(3):436-40. Epub 2006 Feb 3.

26.
27.

Loss of vision once silicone oil has been removed.

Satchi K, Bolton A, Patel CK.

Retina. 2005 Sep;25(6):807-8; author reply 808. No abstract available.

PMID:
16141883
28.

Population pharmacokinetics of imatinib mesylate in patients with chronic-phase chronic myeloid leukaemia: results of a phase III study.

Schmidli H, Peng B, Riviere GJ, Capdeville R, Hensley M, Gathmann I, Bolton AE, Racine-Poon A; IRIS Study Group.

Br J Clin Pharmacol. 2005 Jul;60(1):35-44.

29.

Biologic effects and basic science of a novel immune-modulation therapy.

Bolton AE.

Am J Cardiol. 2005 Jun 6;95(11A):24C-29C; discussion 38C-40C. Review.

PMID:
15925561
30.

Evidence of an anti-inflammatory role for Vasogen's immune modulation therapy.

Nolan Y, Campbell VA, Bolton AE, Lynch MA.

Neuroimmunomodulation. 2005;12(2):113-6.

PMID:
15785113
31.

Role of interleukin-4 in regulation of age-related inflammatory changes in the hippocampus.

Nolan Y, Maher FO, Martin DS, Clarke RM, Brady MT, Bolton AE, Mills KH, Lynch MA.

J Biol Chem. 2005 Mar 11;280(10):9354-62. Epub 2004 Dec 22.

32.

Use of the surface proteins GapC and Mig of Streptococcus dysgalactiae as potential protective antigens against bovine mastitis.

Bolton A, Song XM, Willson P, Fontaine MC, Potter AA, Perez-Casal J.

Can J Microbiol. 2004 Jun;50(6):423-32.

PMID:
15284888
33.

Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects.

Bolton AE, Peng B, Hubert M, Krebs-Brown A, Capdeville R, Keller U, Seiberling M.

Cancer Chemother Pharmacol. 2004 Feb;53(2):102-6. Epub 2003 Nov 7.

PMID:
14605865
34.

Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia.

Hughes TP, Kaeda J, Branford S, Rudzki Z, Hochhaus A, Hensley ML, Gathmann I, Bolton AE, van Hoomissen IC, Goldman JM, Radich JP; International Randomised Study of Interferon versus STI571 (IRIS) Study Group.

N Engl J Med. 2003 Oct 9;349(15):1423-32.

35.

Insurance-based advantages for subordinate co-foundresses in a temperate paper wasp.

Shreeves G, Cant MA, Bolton A, Field J.

Proc Biol Sci. 2003 Aug 7;270(1524):1617-22.

36.

Distinguishing states of awareness from confidence during retrieval: evidence from amnesia.

Rajaram S, Hamilton M, Bolton A.

Cogn Affect Behav Neurosci. 2002 Sep;2(3):227-35.

PMID:
12775187
37.

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.

O'Brien SG, Guilhot F, Larson RA, Gathmann I, Baccarani M, Cervantes F, Cornelissen JJ, Fischer T, Hochhaus A, Hughes T, Lechner K, Nielsen JL, Rousselot P, Reiffers J, Saglio G, Shepherd J, Simonsson B, Gratwohl A, Goldman JM, Kantarjian H, Taylor K, Verhoef G, Bolton AE, Capdeville R, Druker BJ; IRIS Investigators.

N Engl J Med. 2003 Mar 13;348(11):994-1004.

38.

Renal ischemia-reperfusion injury in the rat is prevented by a novel immune modulation therapy.

Tremblay J, Chen H, Peng J, Kunes J, Vu MD, Der Sarkissian S, deBlois D, Bolton AE, Gaboury L, Marshansky V, Gouadon E, Hamet P.

Transplantation. 2002 Nov 27;74(10):1425-33.

PMID:
12451244
39.

Attenuation of LPS-induced changes in synaptic activity in rat hippocampus by Vasogen's Immune Modulation Therapy.

Nolan Y, Minogue A, Vereker E, Bolton AE, Campbell VA, Lynch MA.

Neuroimmunomodulation. 2002;10(1):40-6.

PMID:
12207162
40.

A new chromosomal locus associated with gut-modulated phenotypes in Salmonella enterica serotype typhimurium.

Robey M, Morgan E, Lodge JM, Bolton AJ, Martin GD, Brown NL, Stephen J.

J Med Microbiol. 2002 Mar;51(3):247-63.

PMID:
11871620
41.

Surface-expressed mig protein protects Streptococcus dysgalactiae against phagocytosis by bovine neutrophils.

Song XM, Perez-Casal J, Bolton A, Potter AA.

Infect Immun. 2001 Oct;69(10):6030-7.

42.

Deaths and injuries from house fires.

Istre GR, McCoy MA, Osborn L, Barnard JJ, Bolton A.

N Engl J Med. 2001 Jun 21;344(25):1911-6.

43.

Identification of the acid phosphatase (acpA) gene homologues in pathogenic and non-pathogenic Burkholderia spp. facilitates TnphoA mutagenesis.

Burtnick M, Bolton A, Brett P, Watanabe D, Woods D.

Microbiology. 2001 Jan;147(Pt 1):111-20.

PMID:
11160805
44.

The effect of VAS972 on allergic contact hypersensitivity.

Shivji GM, Suzuki H, Mandel AS, Bolton AE, Sauder DN.

J Cutan Med Surg. 2000 Jul;4(3):132-7.

PMID:
11003717
45.
47.

Reactions of cisplatin hydrolytes with methionine, cysteine, and plasma ultrafiltrate studied by a combination of HPLC and NMR techniques.

el-Khateeb M, Appleton TG, Gahan LR, Charles BG, Berners-Price SJ, Bolton AM.

J Inorg Biochem. 1999 Oct;77(1-2):13-21.

PMID:
10626348
48.

Interaction of Salmonella choleraesuis, Salmonella dublin and Salmonella typhimurium with porcine and bovine terminal ileum in vivo.

Bolton AJ, Osborne MP, Wallis TS, Stephen J.

Microbiology. 1999 Sep;145 ( Pt 9):2431-41.

PMID:
10517596
49.

A histotoxin produced by Salmonella.

Lodge JM, Bolton AJ, Martin GD, Osborne MP, Ketley JM, Stephen J.

J Med Microbiol. 1999 Sep;48(9):811-8.

PMID:
10482291
50.

Invasiveness of Salmonella serotypes Typhimurium, Choleraesuis and Dublin for rabbit terminal ileum in vitro.

Bolton AJ, Martin GD, Osborne MP, Wallis TS, Stephen J.

J Med Microbiol. 1999 Sep;48(9):801-10.

PMID:
10482290

Supplemental Content

Loading ...
Support Center